Page last updated: 2024-09-05

lenalidomide and Encephalopathy, Toxic

lenalidomide has been researched along with Encephalopathy, Toxic in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Anguille, S; Avivi, I; Cavo, M; Chen, D; Cohen, YC; Connors, K; Costa, LJ; Dhakal, B; Dytfeld, D; Einsele, H; Fernández de Larrea, C; Florendo, E; Gilbert, J; Griffin, J; Harrison, SJ; Ho, PJ; Ishida, T; Jackson, CC; Khan, AM; Kim, SJ; Leleu, X; Lendvai, N; Li, K; Lonardi, C; Martínez-López, J; Mateos, MV; Moreau, P; Nagle, S; Oriol, A; Pacaud, L; Patel, N; Popat, R; Roeloffzen, W; San-Miguel, J; Schecter, JM; Sidana, S; Slaughter, A; Spencer, A; Touzeau, C; van de Donk, NWCJ; Yeh, TM; Yong, K; Zudaire, E	1
Barilà, G; Berno, T; Briani, C; Cacciavillani, M; Campagnolo, M; Dalla Torre, C; De March, E; Ermani, M; Lico, A; Lucchetta, M; Salvalaggio, A; Zambello, R	1

Studies

Anguille, S; Avivi, I; Cavo, M; Chen, D; Cohen, YC; Connors, K; Costa, LJ; Dhakal, B; Dytfeld, D; Einsele, H; Fernández de Larrea, C; Florendo, E; Gilbert, J; Griffin, J; Harrison, SJ; Ho, PJ; Ishida, T; Jackson, CC; Khan, AM; Kim, SJ; Leleu, X; Lendvai, N; Li, K; Lonardi, C; Martínez-López, J; Mateos, MV; Moreau, P; Nagle, S; Oriol, A; Pacaud, L; Patel, N; Popat, R; Roeloffzen, W; San-Miguel, J; Schecter, JM; Sidana, S; Slaughter, A; Spencer, A; Touzeau, C; van de Donk, NWCJ; Yeh, TM; Yong, K; Zudaire, E

Barilà, G; Berno, T; Briani, C; Cacciavillani, M; Campagnolo, M; Dalla Torre, C; De March, E; Ermani, M; Lico, A; Lucchetta, M; Salvalaggio, A; Zambello, R

Trials

1 trial(s) available for lenalidomide and Encephalopathy, Toxic

Article	Year
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma. The New England journal of medicine, 2023, Jul-27, Volume: 389, Issue:4 Topics: Antineoplastic Agents, Immunological; B-Cell Maturation Antigen; Drug Resistance, Neoplasm; Humans; Immunotherapy, Adoptive; Lenalidomide; Multiple Myeloma; Neurotoxicity Syndromes; Progression-Free Survival	2023

Other Studies

2 other study(ies) available for lenalidomide and Encephalopathy, Toxic

Article	Year
Lenalidomide long-term neurotoxicity: Clinical and neurophysiologic prospective study. Neurology, 2016, Sep-13, Volume: 87, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Prospective Studies; Recurrence; Sensory Receptor Cells; Severity of Illness Index; Thalidomide; Time Factors	2016
Thalidomide and lenalidomide: overview of the French pharmacovigilance database. Prescrire international, 2012, Volume: 21, Issue:125 Topics: Databases, Factual; France; Hematologic Diseases; Humans; Immunosuppressive Agents; Lenalidomide; Multiple Myeloma; Neurotoxicity Syndromes; Off-Label Use; Pharmacovigilance; Thalidomide; Vascular Diseases	2012

Article

Year

Lenalidomide long-term neurotoxicity: Clinical and neurophysiologic prospective study.

Neurology, 2016, Sep-13, Volume: 87, Issue:11

Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Prospective Studies; Recurrence; Sensory Receptor Cells; Severity of Illness Index; Thalidomide; Time Factors

2016

Thalidomide and lenalidomide: overview of the French pharmacovigilance database.

Prescrire international, 2012, Volume: 21, Issue:125

Topics: Databases, Factual; France; Hematologic Diseases; Humans; Immunosuppressive Agents; Lenalidomide; Multiple Myeloma; Neurotoxicity Syndromes; Off-Label Use; Pharmacovigilance; Thalidomide; Vascular Diseases

2012